TrialX
Image

Effect of Mechanical Power on Dead Space Assessed by Volumetric Capnography: Preliminary Studies and Pilot Testing in ARDS Patients

Effect of Mechanical Power on Dead Space Assessed by Volumetric Capnography: Preliminary Studies and Pilot Testing in ARDS Patients

Recruiting
18 years and older
All
Phase N/A

Overview

This study assesses changes in physiological variables, aiming to determine whether a reduction in the mechanical power delivered by artificial ventilation while maintaining constant peep levels generates a reduction in the Bohrs dead space in patients with moderate to severe acute respiratory distress syndrome (ARDS). Commonly used ventilatory strategies aimed at reducing mechanical power will be applied sequentially to assess their impact. Data obtained from volumetric capnography will be recorded after each ventilatory strategy is applied.

Description

Invasive mechanical ventilation is the cornerstone of the management of patients with Acute Respiratory Distress Syndrome. However, studies have shown that increasing tidal volume and driving pressure leads to negatives outcomes. It has also been observed that an increase in the physiologic dead space is associated with significantly higher mortality. We designed this study to assess these physiological variables, aiming to determine whether the reduction in the mechanical power delivered by artificial ventilation generates a decrease of the Bohrs dead space in patients with moderate to severe ARDS. Therefore, this observational study will describe the effect that mechanical power has on Bohr's dead space and its subcomponents in mechanically ventilated patients with ARDS. Commonly used ventilatory strategies aimed at reducing mechanical power will be applied sequentially to assess their effects. Data obtained from volumetric capnography will be recorded after each ventilatory procedure is implemented. This observational study will be performed in the Intensive Care Unit of a University Hospital.

Protocol design: The protocol will start recording the data during baseline protective ventilation. After 30 minutes of data recording, we studied four levels of setting in mechanical ventilation. Each level will last 30 minutes.

We will analyze the last 20 breaths of each step of the protocol and calculate the average value to obtain the result of dead space and all its variables by volumetric capnography. Respiratory, hemodynamic, and arterial blood gas analysis will also be recorded.

Eligibility

Inclusion Criteria:

  • Age older than 18 years
  • The requirement of invasive mechanical ventilation for more than 4 hours and less than 72 hours
  • Severe hypoxemia (PAFI < 200) secondary to ARDS

Exclusion Criteria:

  • Heart failure stage IV
  • Chronic obstructive pulmonary disease (COPD) on home oxygen
  • Bronchopulmonary fistula
  • Hypovolemic Shock with active hemorrhage
  • Gastrointestinal bleeding
  • Oesophageal Varices
  • Nasopharynx surgery, recent oesophageal or gastric surgery
  • Massive Pulmonary Thromboembolism
  • Catastrophic respiratory failure requiring urgent extracorporeal life support
  • Respiratory acidosis. Hydrogen potential (pH) is less than 7.20 and PaCO2 higher than 60 mmHg at baseline.

Study details
    ADULT RESPIRATORY DISTRESS SYNDROME
    Volumetric Capnography
    Mechanical Power

NCT04435613

Clinica las Condes, Chile

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.